Abstract
Therapeutic resistance is the major challenge in clinic for patients with mantle cell lymphoma (MCL), an aggressive subtype of B-cell lymphoma. In add......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
